203 related articles for article (PubMed ID: 34094641)
1. Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and Death.
Gennaccaro L; Fuchs C; Loi M; Pizzo R; Alvente S; Berteotti C; Lupori L; Sagona G; Galvani G; Gurgone A; Raspanti A; Medici G; Tassinari M; Trazzi S; Ren E; Rimondini R; Pizzorusso T; Zoccoli G; Giustetto M; Ciani E
Aging Dis; 2021 Jun; 12(3):764-785. PubMed ID: 34094641
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.
Galvani G; Mottolese N; Gennaccaro L; Loi M; Medici G; Tassinari M; Fuchs C; Ciani E; Trazzi S
J Neuroinflammation; 2021 Jul; 18(1):155. PubMed ID: 34238328
[TBL] [Abstract][Full Text] [Related]
3. Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder.
Tassinari M; Uguagliati B; Trazzi S; Cerchier CB; Cavina OV; Mottolese N; Loi M; Candini G; Medici G; Ciani E
Neurobiol Dis; 2023 Jun; 182():106146. PubMed ID: 37164289
[TBL] [Abstract][Full Text] [Related]
4. Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder.
Mottolese N; Uguagliati B; Tassinari M; Cerchier CB; Loi M; Candini G; Rimondini R; Medici G; Trazzi S; Ciani E
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759796
[TBL] [Abstract][Full Text] [Related]
5. Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder.
Tassinari M; Mottolese N; Galvani G; Ferrara D; Gennaccaro L; Loi M; Medici G; Candini G; Rimondini R; Ciani E; Trazzi S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955854
[TBL] [Abstract][Full Text] [Related]
6. Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB Agonist.
Ren E; Roncacé V; Trazzi S; Fuchs C; Medici G; Gennaccaro L; Loi M; Galvani G; Ye K; Rimondini R; Aicardi G; Ciani E
Front Cell Neurosci; 2019; 13():169. PubMed ID: 31114483
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder.
Fuchs C; Gennaccaro L; Ren E; Galvani G; Trazzi S; Medici G; Loi M; Conway E; Devinsky O; Rimondini R; Ciani E
Neuropharmacology; 2020 May; 167():107746. PubMed ID: 31469994
[TBL] [Abstract][Full Text] [Related]
8. Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of
Loi M; Gennaccaro L; Fuchs C; Trazzi S; Medici G; Galvani G; Mottolese N; Tassinari M; Giorgini RR; Milelli A; Ciani E
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073043
[TBL] [Abstract][Full Text] [Related]
9. The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo.
Trovò L; Fuchs C; De Rosa R; Barbiero I; Tramarin M; Ciani E; Rusconi L; Kilstrup-Nielsen C
Neurobiol Dis; 2020 May; 138():104791. PubMed ID: 32032735
[TBL] [Abstract][Full Text] [Related]
10. A GABA
Gennaccaro L; Fuchs C; Loi M; Roncacè V; Trazzi S; Ait-Bali Y; Galvani G; Berardi AC; Medici G; Tassinari M; Ren E; Rimondini R; Giustetto M; Aicardi G; Ciani E
Neurobiol Dis; 2021 Jun; 153():105304. PubMed ID: 33621640
[TBL] [Abstract][Full Text] [Related]
11. Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons.
Loi M; Trazzi S; Fuchs C; Galvani G; Medici G; Gennaccaro L; Tassinari M; Ciani E
Mol Neurobiol; 2020 May; 57(5):2244-2262. PubMed ID: 32002787
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.
Fuchs C; Gennaccaro L; Trazzi S; Bastianini S; Bettini S; Lo Martire V; Ren E; Medici G; Zoccoli G; Rimondini R; Ciani E
Neural Plast; 2018; 2018():9726950. PubMed ID: 29977282
[TBL] [Abstract][Full Text] [Related]
13. CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling.
Fuchs C; Medici G; Trazzi S; Gennaccaro L; Galvani G; Berteotti C; Ren E; Loi M; Ciani E
Brain Pathol; 2019 Sep; 29(5):658-674. PubMed ID: 30793413
[TBL] [Abstract][Full Text] [Related]
14. CDKL5-mediated developmental tuning of neuronal excitability and concomitant regulation of transcriptome.
Liao W; Lee KZ
Hum Mol Genet; 2023 Nov; 32(23):3276-3298. PubMed ID: 37688574
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder.
Loi M; Bastianini S; Candini G; Rizzardi N; Medici G; Papa V; Gennaccaro L; Mottolese N; Tassinari M; Uguagliati B; Berteotti C; Martire VL; Zoccoli G; Cenacchi G; Trazzi S; Bergamini C; Ciani E
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982627
[TBL] [Abstract][Full Text] [Related]
16. Behavioral impulsivity is associated with pupillary alterations and hyperactivity in CDKL5 mutant mice.
Viglione A; Sagona G; Carrara F; Amato G; Totaro V; Lupori L; Putignano E; Pizzorusso T; Mazziotti R
Hum Mol Genet; 2022 Nov; 31(23):4107-4120. PubMed ID: 35861639
[TBL] [Abstract][Full Text] [Related]
17. Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling.
Fuchs C; Trazzi S; Torricella R; Viggiano R; De Franceschi M; Amendola E; Gross C; Calzà L; Bartesaghi R; Ciani E
Neurobiol Dis; 2014 Oct; 70(100):53-68. PubMed ID: 24952363
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the GSK3-beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice.
Fuchs C; Fustini N; Trazzi S; Gennaccaro L; Rimondini R; Ciani E
Eur J Neurosci; 2018 May; 47(9):1054-1066. PubMed ID: 29603837
[TBL] [Abstract][Full Text] [Related]
19. Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency Disorder.
Barbiero I; Peroni D; Siniscalchi P; Rusconi L; Tramarin M; De Rosa R; Motta P; Bianchi M; Kilstrup-Nielsen C
Neuropharmacology; 2020 Mar; 164():107897. PubMed ID: 31794725
[TBL] [Abstract][Full Text] [Related]
20. Treatment with FRAX486 rescues neurobehavioral and metabolic alterations in a female mouse model of CDKL5 deficiency disorder.
Fuchs C; Cosentino L; Urbinati C; Talamo MC; Medici G; Quattrini MC; Mottolese N; Pietraforte D; Fuso A; Ciani E; De Filippis B
CNS Neurosci Ther; 2022 Nov; 28(11):1718-1732. PubMed ID: 35932179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
